Yang Zhang

Dr. Yang Zhang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Journal of Hazardous Materials
Verified
Journal Article
Open access
TWTianyi Wang
Tianyi Wang
NLNa Li
Na Li
ZZZehao Zhao
Zehao Zhao
YZYang Zhang
Yang Zhang
LLLi Lin
Li Lin
YZYong Zeng
Yong Zeng
Microplastic (MP) contamination in human tissues is an emerging environmental and clinical concern, yet its relevance to organ transplantation remains poorly understood. This study characterized MPs in kidney transplantation-associated donor tissues and examined their relationship with early postoperative blood pressure (BP) in recipients. Tissue samples, including kidney, adrenal gland, renal artery, renal vein, and ureter, were collected from 28 kidney transplant donors. MPs were extracted from each tissue and analyzed using a multimodal strategy: pyrolysis-gas chromatography-mass spectrometry for polymer quantification, laser direct infrared spectroscopy (LD-IR) for particle identification, and scanning electron microscopy (SEM) for morphological assessment. Polyethylene (PE) and polyvinyl chloride (PVC) were consistently the most abundant polymers by mass, with PE concentrations ranging from 25.7 to 98.9 μg/g and PVC from 31.2 to 65.4 μg/g across tissues. LD-IR analysis showed that kidney tissue contained 293 MP particles (6 polymer types), adrenal gland 2017 (9 polymer types), renal artery 881 (8 polymer types), renal vein 1528 (10 polymer types), and ureter 1672 (10 polymer types). MPs measuring 20-100 μm accounted for 47.1-54.9 % of its content across tissues, while 100-500 μm MPs comprised 45.1-52.9 %. Postoperative BP was assessed 15 days post-transplantation. While moderate, tissue-specific correlations between certain MP types and BP were observed (e.g., natural rubber in adrenal glands, polycarbonate in renal arteries, polypropylene in renal veins, and butadiene rubber in ureters), most associations were not statistically significant. Negative values were obtained for linear regression and FDR correction, emphasizing the preliminary nature of the results. This highlights the need for further investigation of the clinical impact of MP.

21 January 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
ZLZhennan Li
Zhennan Li
TXTingfeng Xu
Tingfeng Xu
ZWZhiqiang Wang
Zhiqiang Wang
YDYaodong Ding
Yaodong Ding
YZYang Zhang
Yang Zhang
YZYong Zeng
Yong Zeng
Background: Data on the predictive value of coronary computed tomography angiography–derived fractional flow reserve (CT‐FFR) for long‐term outcomes are limited. Methods and Results: A retrospective pooled analysis of individual patient data was performed. Deep‐learning‐based CT‐FFR was calculated. All patients enrolled were followed‐up for at least 5 years. The primary outcome was major adverse cardiovascular events. The secondary outcome was death or nonfatal myocardial infarction. Predictive abilities for outcomes were compared among 3 models (model 1, constructed using clinical variables; model 2, model 1+coronary computed tomography angiography–derived anatomical parameters; and model 3, model 2+CT‐FFR). A total of 2566 patients (median age, 60 [53–65] years; 56.0% men) with coronary artery disease were included. During a median follow‐up time of 2197 (2127–2386) days, 237 patients (9.2%) experienced major adverse cardiovascular events. In multivariable‐adjusted Cox models, CT‐FFR≤0.80 (hazard ratio [HR], 5.05 [95% CI, 3.64–7.01]; P <0.001) exhibited robust predictive value. The discriminant ability was higher in model 2 than in model 1 (Harrell's C‐statistics, 0.79 versus 0.64; P <0.001) and was further promoted by adding CT‐FFR to model 3 (Harrell's C‐statistics, 0.83 versus 0.79; P <0.001). Net reclassification improvement was 0.264 ( P <0.001) for model 2 beyond model 1. Of note, compared with model 2, model 3 also exhibited improvement (net reclassification improvement=0.085; P =0.001). As for predicting death or nonfatal myocardial infarction, only incorporating CT‐FFR into model 3 showed improved reclassification (net reclassification improvement=0.131; P =0.021). Conclusions: CT‐FFR provides strong and incremental prognostic information for predicting long‐term outcomes. The combined models incorporating CT‐FFR exhibit modest improvement of prediction abilities, which may aid in risk stratification and decision‐making.

5 August 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
YZYang Zhang
Yang Zhang
QLQuan Li
Quan Li
YYYicong Ye
Yicong Ye
XZXiliang Zhao
Xiliang Zhao
LZLiang Zhang
Liang Zhang
YZYong Zeng
Yong Zeng
Background: Angiography‐derived index of microcirculatory resistance (IMR) has emerged as a feasible alternative to wire‐based IMR, due to the elimination of specialized wire and simplifying of the procedure. However, the differences in diagnostic accuracy between hyperemic and resting angiography with this technology remain underexplored. Methods: This prospective, multicenter study was conducted to evaluate the feasibility and diagnostic accuracy of x‐ray angiography–derived IMR (xaIMR) in patients with chronic coronary syndrome using wire‐based functional indices as the reference. Angiography‐derived functional indices were calculated using a computational fluid dynamics model. The xaIMR indices were derived from hyperemic and resting angiography, respectively. Results: A total of 139 vessels were included in the analysis of the present study. Both hyperemic xaIMR ( r =0.82; P <0.001) and resting xaIMR (R‐xaIMR) ( r =0.25; P =0.003) exhibited positive linear correlations with wire‐based IMR. Notably, hyperemic xaIMR was associated with a higher diagnostic yield (area under the receiver operating characteristic curve) than resting xaIMR (area under the receiver operating characteristics curve, 0.95 versus 0.72; P <0.001). Significant differences in diagnostic yield between these modalities were observed in vessels with compromised coronary flow reserve (<2.0). In contrast, such differences were not observed in vessels with normal coronary flow reserve (≥2.0). Conclusions: xaIMR, especially derived from hyperemic angiography, is a reliable, noninvasive alternative to wire‐based IMR for assessing coronary microcirculatory resistance in chronic coronary syndrome. However, resting angiography‐derived xaIMR may have limited diagnostic accuracy in patients with reduced coronary flow reserve. Further studies are warranted to validate these findings in broader populations.

28 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
TWTianyi Wang
Tianyi Wang
WWWenjie Wang
Wenjie Wang
LLLi Lin
Li Lin
YZYang Zhang
Yang Zhang
ZZZehao Zhao
Zehao Zhao
YZYong Zeng
Yong Zeng
Cardiovascular recovery after kidney transplantation varies substantially, even early after surgery. We examined whether microbiota-derived uremic toxins, post-transplant gut microbiome profiles, and paired plasma metabolic changes were associated with blood pressure normalization and cardiac functional improvement at postoperative day 14. Among 624 kidney transplant recipients, blood pressure was measured before transplantation and at day 14, and plasma indoxyl sulfate and p-cresyl sulfate were quantified by LC–MS/MS at both time points. Early hypertension remission was predefined as mean systolic blood pressure <140 mmHg and diastolic blood pressure <90 mmHg without antihypertensive medication at day 14; 468 recipients met these criteria, whereas 156 had persistent hypertension. Clinical phenotyping, echocardiography, paired plasma metabolomics, post-transplant gut metagenomics, bidirectional Mendelian randomization, mediation analysis, endothelial cell assays, and mouse fecal microbiota transplantation were integrated.Both toxins declined significantly by day 14, with larger reductions in the remission group. Greater toxin reductions were independently associated with blood pressure normalization and improved cardiac indices, including higher left ventricular ejection fraction, lower E/e′ ratio, and reduced NT-proBNP. The remission group also showed greater microbial diversity, enrichment of short-chain fatty acid-producing taxa such as Faecalibacterium, Roseburia, and Bifidobacterium, and lower abundance of aromatic amino acid-derived toxin pathways. Paired metabolomics demonstrated lower toxin-related metabolites and stronger butyrate- and propionate-associated signals. Mendelian randomization supported directional associations of genetically predicted indoxyl sulfate and p-cresyl sulfate with hypertension and heart failure, without evidence of reverse causality. In endothelial cells, these toxins increased oxidative stress and inflammation, reduced nitric oxide, and impaired angiogenesis; butyrate and remission-group serum partly reversed these effects. In mice, fecal microbiota transplantation from recipients with persistent hypertension transmitted blood pressure elevation, adverse metabolic signatures, and aortic endothelial injury, whereas butyrate attenuated these abnormalities.These findings identify a kidney–gut–metabolite–vascular axis associated with early cardiovascular improvement after kidney transplantation and support microbiota-derived toxin reduction and toxin-to-short-chain-fatty-acid balance as candidate biomarkers requiring external and long-term validation.

20 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YZYang Zhang
Yang Zhang
YLYajuan Liu
Yajuan Liu
XDXin Du
Xin Du
XZXiliang Zhao
Xiliang Zhao
GCGuojie Cheng
Guojie Cheng
YZYong Zeng
Yong Zeng
BackgroundComprehensive pharmacological therapy remains essential after coronary revascularization to improve coronary microcirculatory function and reduce recurrent angina. However, the impact of oral nicorandil on patient-reported health outcomes following revascularization has not been well established in real-world settings.MethodsWe analyzed patients with angina who underwent coronary revascularization in the GREAT registry. Patients were categorized according to oral nicorandil use at enrollment into nicorandil and non-nicorandil groups. Health status was assessed using the Seattle Angina Questionnaire (SAQ) at 3, 6, 9, and 12 months. The SAQ summary score was calculated as the mean of physical limitation (PL), angina frequency (AF), and quality of life (QoL). Propensity score matching (PSM) was performed to adjust for baseline differences.ResultsA total of 1038 patients were included, of whom 390 (37.6%) received nicorandil. After PSM, 321 matched pairs were identified. At 12 months, the nicorandil group showed greater improvements in SAQ summary score (19.2 ± 14.1 vs. 14.9 ± 12.9), SAQ-PL (13.9 ± 17.2 vs. 8.5 ± 16.4), and SAQ-QoL (19.5 ± 20.1 vs. 15.2 ± 20.5) (all P < 0.01). Similar trends were observed at earlier time points. More patients receiving nicorandil achieved ≥20-point improvements in SAQ summary score and SAQ-PL across follow-ups. Mixed-effects models confirmed an independent association between nicorandil use and improved SAQ scores.ConclusionsIn this real-world registry, oral nicorandil was associated with significant improvement in patient-reported health status after coronary revascularization.

28 May 2021 in Research Square
Verified
Preprint
Open access
PDF file
YZYang Zhang
Yang Zhang
XZXiliang Zhao
Xiliang Zhao
YYYicong Ye
Yicong Ye
QLQuan Li
Quan Li
YZYong Zeng
Yong Zeng
Purpose:To investigate the association between CYP2C19 gene polymorphism and the risk of ischemic and bleeding complications in the different period after percutaneous coronary intervention (PCI) among patients who received clopidogrel.Methods:Between October 2015 and January 2017, CYP2C19 genotyped patients who were treated clopidogrel after PCI were enrolled this observational cohort study. Included patients were categorized as non-loss-of-function metabolizers (NLOFMs), intermediate metabolizers (IMs) and poor metabolizers (PMs) based on CYP2C19 genotype. The primary outcome was a composite of any-cause mortality, nonfatal myocardial infarction, nonfatal ischemic stroke and stent thrombosis occurring during exposure to clopidogrel. The rates of clinical outcome events were compared between CYP2C19 phenotypes. Landmark analyses were processed at 90 days and 1-year post-PCI.Results:Of 1,341 patients, 161 (12.0%) had two copy of loss-of-function (LOF) alleles, 621(46.3%) had one LOF allele, and 559 (41.7%) had no LOF allele. At the 3-month follow-up, the primary outcome events were more frequent in carriers of two LOF alleles (5.6%) than in noncarriers (1.8%) (adjusted HR 2.944, 95% CI 1.184-7.321, p = 0.020). A similar finding was observed among in patients with acute coronary syndrome indications at the index PCI (adjusted HR 3.046, 95% CI 1.237-7.501, p = 0.015). These differences did not persist within the subsequent 9 months of follow-up, among either all-comers or subjects with ACS. The incidences of bleeding outcome events were similar among CYP2C19 phenotypes throughout the follow-up period.Conclusion:These data demonstrate a higher risk for ischemic events in patients with two CYP2C19 LOF alleles who are prescribed clopidogrel, previously seen at 3 months following PCI, that is not sustained for 12 months. These findings emphasize the need to place greater weight on a PM result during early antiplatelet therapy de-escalating decisions.